Abstract:The fibrillation of therapeutic peptides can present significant quality concerns and poses challenges for manufacturing and storage. A fundamental understanding of the mechanisms of fibrillation is critical for the rational design of fibrillation-resistant peptide drugs and can accelerate product development by guiding the selection of solution-stable candidates and formulations. The studies reported here investigated the effects of structural modifications on the fibrillation of a 29-residue peptide (PepA) and two sequence modified variants (PepB, PepC). The C-terminus of PepA was amidated, whereas both PepB and PepC retained the carboxylate, and Ser16 in PepA and PepB was substituted with a helix-stabilizing residue, α-aminoisobutyric acid (Aib), in PepC. In thermal denaturation studies by far-UV CD spectroscopy and fibrillation kinetic studies by fluorescence and turbidity measurements, PepA and PepB showed heat-induced conformational changes and were found to form fibrils, whereas PepC did not fibrillate and showed only minor changes in the CD signal. Pulsed hydrogen-deuterium exchange mass spectrometry (HDX-MS) showed a high degree of protection from HD exchange in mature PepA fibrils and its proteolytic fragments, indicating that most of the sequence had been incorporated into the fibril structure and occurred nearly simultaneously throughout the sequence. The effects of the net peptide charge and formulation pH on fibrillation kinetics were investigated. In real-time stability studies of two formulations of PepA at pH's 7.4 and 8.0, analytical methods detected significant changes in the stability of the formulations at different time points during the study, which were not observed during accelerated studies. Additionally, PepA samples were withdrawn from real-time stability and subjected to additional stress (40 °C, continuous shaking) to induce fibrillation; an approach that successfully amplified oligomers or prefibrillar species previously undetected in a thioflavin T assay. Taken together, these studies present an approach to differentiate and characterize fibrillation risk in structurally related peptides under accelerated and real-time conditions, providing a model for rapid, iterative structural design to optimize the stability of therapeutic peptides.

Structural Stability and Immunogenicity of Peptides

A Test of AMBER Force Fields in Predicting the Secondary Structure of Α-Helical and Β-Hairpin Peptides

Boosting stability: a hierarchical approach for self-assembling peptide structures

Thermodynamic Basis for the Stabilization of Helical Peptoids by Chiral Sidechains

Stability of Nanopeptides: Structure and Molecular Exchange of Self-assembled Peptide Fibers

Understanding the role of intramolecular ion-pair interactions in conformational stability using an ab initio thermodynamic cycle

Survey of retail alfalfa sprouts and mushrooms for the presence of Escherichia coil O157:H7, Salmonella, and Listeria with BAX, and evaluation of this polymerase chain reaction-based system with experimentally contaminated samples.

Functional structures and folding dynamics of two peptides

Investigating the side-chain structural organization behind the stability of protein folding and binding

Thermodynamics and Kinetics of Folding of a Small Peptide

On the propensity of Asn-Gly-containing heptapeptides to form $β$-turn structures : comparison between ab initio quantum mechanical calculations and Molecular Dynamics simulations

Prediction of peptide structure: How far are we?

Impact of vibrational entropy on the stability of unsolvated peptide helices with increasing length

Changing the determinants of protein stability from covalent to non-covalent interactions by in vitro evolution: a structural and energetic analysis

Structural preferences of two unnatural hybrid octapeptides with and without the crystal environment: a computational study

Structural Selection of Ionic-Complementary Peptides with Electrostatic Interactions

Elucidating Molecular Design Principles for Charge-Alternating Peptides

Folding and Dimerization of the Ionic Peptide EAK 16-IV.

TISSUE METABOLISM IN EXPERIMENTAL TOXEMIA OF PREGNANCY.

Biophysical inference of epistasis and the effects of mutations on protein stability and function

A Model Study to Assess Fibrillation and Product Stability to Support Peptide Drug Design